Reply to Alexander Andreev-Drakhlin, Jianjun Gao, Arlene Siefker-Radtke. Levelling the Evidence: A Comparison of Neoadjuvant and Adjuvant Treatment for Upper Tract Urothelial Carcinoma. Eur Urol 2021;79:655-6

Affiliations

¹ Department of Urology, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Division of Urology & Center for Surgery & Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: jeffrey.leow@mail.harvard.edu.
² Department of Urology, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
³ Division of Urology & Center for Surgery & Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
⁴ Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
⁵ Barts Cancer Institute, Barts Health and the Royal Free NHS Trusts, London, UK.
⁶ Beth Israel Deaconess Medical Center and PSMAR-IMIM Research Lab, Harvard Medical School, Boston, MA, USA.

Editorial

Jeffrey J Leow et al. Eur Urol. 2021 May.

. 2021 May;79(5):657-658.

doi: 10.1016/j.eururo.2020.10.005. Epub 2020 Oct 17.

¹ Department of Urology, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Division of Urology & Center for Surgery & Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: jeffrey.leow@mail.harvard.edu.
² Department of Urology, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
³ Division of Urology & Center for Surgery & Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
⁴ Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
⁵ Barts Cancer Institute, Barts Health and the Royal Free NHS Trusts, London, UK.
⁶ Beth Israel Deaconess Medical Center and PSMAR-IMIM Research Lab, Harvard Medical School, Boston, MA, USA.

No abstract available

Comment on

Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.
Leow JJ, Chong YL, Chang SL, Valderrama BP, Powles T, Bellmunt J. Leow JJ, et al. Eur Urol. 2021 May;79(5):635-654. doi: 10.1016/j.eururo.2020.07.003. Epub 2020 Aug 12. Eur Urol. 2021. PMID: 32798146
Levelling the Evidence: A Comparison of Neoadjuvant and Adjuvant Treatment for Upper Tract Urothelial Carcinoma.
Andreev-Drakhlin A, Gao J, Siefker-Radtke A. Andreev-Drakhlin A, et al. Eur Urol. 2021 May;79(5):655-656. doi: 10.1016/j.eururo.2020.08.033. Epub 2020 Sep 10. Eur Urol. 2021. PMID: 32921520 No abstract available.